Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species
- PMID: 2030579
Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species
Abstract
Endothelial damage may follow exposure to toxic oxygen species generated by closely apposed ("marginated") granulocytes. Because iron markedly catalyzes oxidant damage in diverse systems, we wondered whether intercalculated heme, and/or its constituent iron, might potentiate oxidant damage of endothelium. Cultured monolayers of porcine aortic endothelial cells were exposed for brief periods to purified hemin. Uptake of heme was rapid, dose dependent, and not reversible by buffer or serum washes. Despite high levels of cell-associated heme, no direct heme-mediated cytotoxicity occurred, but heme-loaded endothelium became highly sensitive to oxidant challenge by (a) reagent H2O2, (b) enzymatically generated oxidants (xanthine/xanthine oxidase), or (c) phorbol-activated polymorphonuclear leukocytes. An increase in endothelial cell lipid peroxidation accompanied heme-augmented oxidant cytolysis, and both parameters were reduced in parallel by micromolar amounts of the hydrophobic oxygen radical scavenger/iron chelator U74500A. Endothelial uptake of heme was inhibited by a specific heme-binding protein, hemopexin. Concomitantly, hemopexin completely blocked augmented H2O2- and polymorphonuclear leukocyte-mediated cytotoxicity but only if added simultaneously and stoichiometrically with hemin. Significant loss of protection occurred if hemopexin addition was delayed 15 minutes, and protection was completely lost after a 60-minute interval. The iron moiety of heme was critical to oxidant sensitization because neither iron-free protoporphyrin IX nor tin-protoporphyrin was able to sensitize endothelial cells to H2O2 or activated polymorphonuclear leukocytes. These results may provide mechanistic insights into atherogenesis, reperfusion injury, and the organ injury accompanying hemoglobinemia or myoglobinemia.
Similar articles
-
Heme uptake by endothelium synergizes polymorphonuclear granulocyte-mediated damage.Trans Assoc Am Physicians. 1990;103:174-9. Trans Assoc Am Physicians. 1990. PMID: 2132529
-
Ferritin: a cytoprotective antioxidant strategem of endothelium.J Biol Chem. 1992 Sep 5;267(25):18148-53. J Biol Chem. 1992. PMID: 1517245
-
Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy.Cancer Res. 1993 Nov 1;53(21):5308-13. Cancer Res. 1993. PMID: 8221666
-
Heme, heme oxygenase and ferritin in vascular endothelial cell injury.Mol Nutr Food Res. 2005 Nov;49(11):1030-43. doi: 10.1002/mnfr.200500076. Mol Nutr Food Res. 2005. PMID: 16208635 Review.
-
Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment.Antioxid Redox Signal. 2007 Dec;9(12):2119-37. doi: 10.1089/ars.2007.1787. Antioxid Redox Signal. 2007. PMID: 17767398 Review.
Cited by
-
Mechanisms and therapeutic implications of RTA 408, an activator of Nrf2, in subarachnoid hemorrhage-induced delayed cerebral vasospasm and secondary brain injury.PLoS One. 2020 Oct 5;15(10):e0240122. doi: 10.1371/journal.pone.0240122. eCollection 2020. PLoS One. 2020. PMID: 33017422 Free PMC article.
-
Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress.Thorax. 2012 Dec;67(12):1032-9. doi: 10.1136/thoraxjnl-2012-201781. Epub 2012 Oct 2. Thorax. 2012. PMID: 23033361 Free PMC article.
-
Interactions of reactive sulfur species with metalloproteins.Redox Biol. 2023 Apr;60:102617. doi: 10.1016/j.redox.2023.102617. Epub 2023 Jan 27. Redox Biol. 2023. PMID: 36738685 Free PMC article. Review.
-
Multifaceted Roles of the KEAP1-NRF2 System in Cancer and Inflammatory Disease Milieu.Antioxidants (Basel). 2022 Mar 11;11(3):538. doi: 10.3390/antiox11030538. Antioxidants (Basel). 2022. PMID: 35326187 Free PMC article. Review.
-
Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics.Blood. 2022 Oct 27;140(17):1837-1844. doi: 10.1182/blood.2022015596. Blood. 2022. PMID: 35660854 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources